Truvian Sciences Snares $105M for its Many-in-One Blood Testing Machine

February 24, 2021

By

With its eyes set on securing an FDA clearance for its automated bench top blood testing system, Truvian Sciences has raised more than $105 million in new financing for the final steps of its development. The series C round will also help scale up the company’s commercialization teams in preparation for launch—alongside several new appointments to its C-suite and board of directors

Tags